Facilitated by the SciLifeLab Chemical Biology Consortium Sweden (CBCS), researchers from Karolinska Institutet, Umeå University, and the University of Bonn, have identified a new group of molecules, exhibiting antibacterial properties against many antibiotic-resistant bacteria. Since the molecules can easily be modified, the hope is to develop new antibiotics with a minimal amount of side effects.
exploring biology with small molecules